Question 2 of 7: Implant Corrosion, Bioactivity vs. Biocompatibility, Opsonization, Paracrine Self-Regulation, and Macrophage Function

Question 2: Implant Corrosion, Bioactivity vs. Biocompatibility, Opsonization, Paracrine Self-Regulation, and Macrophage Function (20 marks — any 4 of 5 parts; all 5 answered)

Question text not reproduced: the examination questions are © Engineers and Geoscientists BC. Open the official past paper (linked at the top of this page) to read the question, then follow the worked solution below.

(a) Corrosion of a single-alloy interfacial screw. Even though the screw is a single alloy, two distinct electrochemical mechanisms can localize attack exactly at the bone/soft-tissue interface. (1) Differential-aeration (crevice) corrosion: the buried, in-bone segment sits in a stagnant, oxygen-depleted micro-environment, while the soft-tissue-exposed segment sees a comparatively oxygen-rich, well-perfused environment. This oxygen gradient sets up a concentration cell along the single piece of metal — the low-oxygen (in-bone) region becomes the anode and corrodes preferentially, while the oxygen-rich region is cathodically protected — and any micro-gap at the bone-implant contact (a true crevice) locally acidifies and concentrates chloride, breaking down the passive Cr₂O₃ film and accelerating attack right at the boundary. (2) Fretting corrosion (mechanically-assisted corrosion): cyclic micromotion between the screw and the bone/plate at this same interface repeatedly abrades the thin protective passive oxide film faster than it can repassivate, continuously exposing bare, chemically reactive metal; the freshly exposed metal corrodes preferentially at the fretting site even though the bulk alloy is identical everywhere else on the screw.

(b) No — a bioactive material is not always biocompatible. Biocompatible means the material elicits an appropriate host response for its specific application (it does not provoke an excessive, unresolved, or harmful local/systemic reaction). Bioactive means the material is deliberately designed to elicit a specific biological or chemical response from the host tissue (e.g., forming a direct chemical bond with bone via surface apatite-layer formation, as bioactive glass does). These are independent axes: a material can be strongly bioactive — genuinely capable of stimulating the intended biological response — yet still fail to be biocompatible if that response is excessive or poorly controlled for the application. The clearest example is recombinant bone morphogenetic protein (rhBMP-2) delivered on a simple collagen sponge for spinal fusion: it is highly osteoinductive (bioactive) but the uncontrolled burst-release profile has been linked to ectopic bone formation, severe local swelling, and inflammatory complications at supra-physiological clinical doses — i.e., a bioactive material producing an adverse host response, and therefore falling short of biocompatibility for that use.

(c) Two reasons the authors are wrong. First, an 8-hour Western blot is a single snapshot of a dynamic, evolving protein layer, not a prediction of its eventual composition. By the Vroman effect (Question 1(b)), an initially abundant, high-mobility protein such as albumin is exactly the kind of protein that dominates a surface early and is then progressively displaced by lower-abundance, higher-affinity proteins (fibrinogen, IgG, complement C3b/iC3b, high-molecular-weight kininogen) over the following hours to days — and it is precisely these later-arriving proteins that drive opsonization and chronic inflammatory recognition. Albumin dominance at 8 h therefore says very little about the layer's composition (and hence the inflammatory potential) at 24–72 h, when the chronic-inflammation/foreign-body cascade is actually being decided. Second, "abundant in blood" does not mean "biologically inert once surface-adsorbed." Any plasma protein, including albumin, can undergo conformational change (denaturation) upon adsorption to a synthetic surface, exposing cryptic epitopes; surface-bound, denatured protein of essentially any identity can trigger the alternative complement pathway (spontaneous C3b deposition directly onto the surface, independent of an antibody-mediated classical-pathway trigger) and be recognized by macrophage scavenger and complement receptors. Opsonization and macrophage recognition therefore do not require that the dominant adsorbed protein be a "classical" opsonin like IgG or fibrinogen — the authors' inference from "mostly albumin" to "low inflammatory risk" does not follow from either the dynamics or the surface chemistry of protein adsorption.

(d) Paracrine self-regulation via membrane receptors. Cells limit their own sensitivity to a sustained paracrine signal chiefly through two receptor-level mechanisms. Receptor downregulation: sustained ligand binding drives receptor internalization (endocytosis) and lysosomal degradation, reducing the number of surface receptors available to bind further ligand and so blunting the cell's maximal response to continued signal. Receptor desensitization: ligand-bound receptors (classically G-protein-coupled receptors) are phosphorylated by specific kinases (e.g., GRKs), which recruits β-arrestin to uncouple the receptor from its downstream signal-transduction machinery without necessarily removing it from the membrane — a faster, more readily reversible form of self-limitation than downregulation. A concrete example of why this matters: during wound healing, fibroblasts are exposed to a sustained paracrine growth-factor signal (e.g., PDGF, TGF-β) from the provisional matrix and infiltrating inflammatory cells; receptor downregulation on those fibroblasts is what allows the proliferative phase of healing to self-terminate at the appropriate time rather than driving unchecked fibroblast proliferation, which would otherwise manifest as excessive, pathological fibrosis around a wound or implant.

(e) Three macrophage functions in the host response. (1) Phagocytosis and degradation of particulate debris. Stimulus: opsonized particles (complement C3b/iC3b- or IgG-coated debris, wear particles, or dead cells) recognized via complement and Fc receptors on the macrophage surface; the macrophage engulfs and enzymatically/oxidatively degrades material small enough to internalize. (2) Secretion of pro-inflammatory and chemotactic mediators. Stimulus: pattern-recognition-receptor (e.g., Toll-like receptor) engagement by the adsorbed-protein layer or direct contact with the biomaterial surface, which drives release of cytokines and chemokines (TNF-α, IL-1, IL-6, MCP-1) that recruit further monocytes/leukocytes and sustain the inflammatory response at the implant site. (3) Fusion into multinucleated foreign body giant cells (FBGCs). Stimulus: "frustrated phagocytosis" — the macrophage physically cannot internalize a surface or particle that is too large relative to its own size — combined with IL-4/IL-13 signalling, which drives macrophage-macrophage fusion; the resulting FBGCs persist at the implant interface indefinitely, continuing to release reactive oxygen species and degradative enzymes that can drive material surface degradation and, for wear-debris particles, contribute to aseptic loosening.